Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

bioAffinity Technologies (BIAF) Depreciation Expense (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Depreciation Expense for 4 consecutive years, with $37529.0 as the latest value for Q4 2025.

  • Quarterly Depreciation Expense fell 12.33% to $37529.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $170359.0 through Dec 2025, up 4.94% year-over-year, with the annual reading at $170359.0 for FY2025, 4.94% up from the prior year.
  • Depreciation Expense for Q4 2025 was $37529.0 at bioAffinity Technologies, down from $44599.0 in the prior quarter.
  • The five-year high for Depreciation Expense was $166284.0 in Q4 2023, with the low at $800.0 in Q3 2022.
  • Average Depreciation Expense over 4 years is $42488.4, with a median of $40357.5 recorded in 2024.
  • The sharpest move saw Depreciation Expense skyrocketed 5536.88% in 2023, then plummeted 74.26% in 2024.
  • Over 4 years, Depreciation Expense stood at $7282.0 in 2022, then surged by 2183.49% to $166284.0 in 2023, then tumbled by 74.26% to $42806.0 in 2024, then dropped by 12.33% to $37529.0 in 2025.
  • According to Business Quant data, Depreciation Expense over the past three periods came in at $37529.0, $44599.0, and $44468.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.